10/11/2015 (Agence Europe) - WTO grants SMES 17-year TRIPS waiver for access to medicines. On Friday 6 November, the WTO's special committee on trade-related aspects of intellectual property rights (the TRIPS Council) decided to grant the least developed countries (LDCs) a waiver to the TRIPS Agreement as regards patents for pharmaceuticals until 2033. This decision keeps the option open to extend the waiver beyond this date. The EU, which supports the indefinite extension of the waiver for...